1. Cell Cycle/DNA Damage Cytoskeleton Apoptosis
  2. Microtubule/Tubulin Apoptosis
  3. Tubulin polymerization-IN-84

Tubulin polymerization-IN-84 通过靶向秋水仙碱结合口袋来抑制微管蛋白 (Tubulin) 聚合,IC50 为 10.9 μM。Tubulin polymerization-IN-84 对 Jurkat、B16-F10、HCT116 和 MDA-MB-231 细胞具有抗增殖活性 (IC50 分别为 60 nM、380 nM、138 nM 和 1.054 μM)。Tubulin polymerization-IN-84 可诱导 B16-F10 细胞发生 G2/M 期阻滞并诱导凋亡 (apoptosis)。Tubulin polymerization-IN-84在 B16-F10 黑色素瘤模型中抑制肿瘤生长,并在与 PD-L1 单抗联用时增强体内抗肿瘤免疫反应,适用于 T 细胞急性淋巴细胞白血病、黑色素瘤、结肠癌和乳腺癌的相关研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Tubulin polymerization-IN-84

Tubulin polymerization-IN-84 Chemical Structure

CAS No. : 2982893-14-9

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Tubulin polymerization-IN-84 inhibits tubulin polymerization by targeting the colchicine-binding pocket, with anIC50 = 10.9 μM. Tubulin polymerization-IN-84 shows antiproliferative activity against Jurkat, B16-F10, HCT116, and MDA-MB-231 cells (IC50 = 60 nM, 380 nM, 138 nM, and 1.054 μM). Tubulin polymerization-IN-84 induces G2/M-phase arrest and apoptosis in B16-F10 cells. Tubulin polymerization-IN-84 suppresses tumor growth in a B16-F10 melanoma model and potentiates anti-tumor immunity in combination with a PD-L1 mAb for the research of T-cell acute lymphoblastic leukemia, melanoma, colon cancer, and breast cancer.

体外研究
(In Vitro)

Tubulin polymerization-IN-84 (compound 5b) 可抑制 Jurkat、B16-F10、HCT116 和 MDA-MB-231 细胞增殖 (IC50 分别为 60 nM、380 nM、138 nM 和 1.054 μM)[1]
Tubulin polymerization-IN-84 (0.1-5 μM; 24 h) 可剂量依赖性抑制 B16-F10 细胞的伤口愈合/迁移及克隆形成[1]
Tubulin polymerization-IN-84 (0.5-5 μM;48 h) 可诱导 B16-F10 细胞 G2/M 期阻滞 (G2/M:对照 9.75%,5 μM 时 81.1%)[1]
Tubulin polymerization-IN-84 (0.5-5 μM;48 h) 可诱导 B16-F10 细胞凋亡[1]
Tubulin polymerization-IN-84 可与 β-tubulin 直接结合 (KD = 31.84 μM)[1]
Tubulin polymerization-IN-84 (0.1-5 μM) 以浓度依赖的方式与 EBI 竞争结合 B16-F10 细胞中 β-微管蛋白的秋水仙碱结合位点[1]
Tubulin polymerization-IN-84 (0.5-5 μM;12 h) 可导致 B16-F10 细胞胞质微管网络解聚[1]
Tubulin polymerization-IN-84 (0.5-5 μM;6 h) 可剂量依赖性破坏 HUVEC 在 Matrigel 上的毛细血管样管网形成并减少连接点[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Migration Assay [1]

Cell Line: B16-F10
Concentration: 0.1 μM; 0.5 μM; 1 μM; 5 μM
Incubation Time: 24 h
Result: Dose-dependently suppressed wound closure and decreased migration rate versus control.

Cell Proliferation Assay[1]

Cell Line: B16-F10
Concentration: 0.5 μM; 1 μM; 5 μM
Incubation Time: 24 h
Result: Dose-dependently suppressed colony formation and reduced colony numbers versus control.

Cell Cycle Analysis[1]

Cell Line: B16-F10
Concentration: 0.5 μM; 1 μM; 5 μM
Incubation Time: 48 h
Result: Increased the proportion of cells arrested at G2/M phase in a dose-dependent manner (9.75% in control vs 81.1% at 5 μM).

Apoptosis Analysis[1]

Cell Line: B16-F10
Concentration: 0.1 μM; 0.5 μM; 1 μM; 5 μM
Incubation Time: 48 h
Result: Increased total apoptotic cells in a dose-dependent manner (14.79% in control vs 21.22%/23.65%/35.66% at 0.5/1/5 μM).

Western Blot Analysis[1]

Cell Line: B16-F10
Concentration: 0.1 μM; 0.5 μM; 1 μM; 5 μM
Incubation Time: After treatment
Result: Competitively inhibited EBI-induced β-tubulin adduct formation in a concentration-dependent manner, indicating binding to the colchicine-binding site of β-tubulin.

Immunofluorescence[1]

Cell Line: B16-F10
Concentration: 0.5 μM; 1 μM; 5 μM
Incubation Time: 12 h
Result: Induced disassembly of cytoplasmic microtubule networks compared with control.
体内研究
(In Vivo)

Tubulin polymerization-IN-84 (compound 5b) (10 mg/kg;腹腔注射 i.p.;每日一次 QD;14 天) 可抑制 C57BL/6 小鼠 B16-F10 黑色素瘤肿瘤生长 (TGI = 27.5%) ,并在与 PD-L1 单抗联用 (10 + 10 mg/kg) 时进一步增强疗效 (TGI = 36.2%),且未见显著体重下降[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 mice bearing established B16-F10 melanoma tumors[1]
Dosage: 10 + 10 mg/kg (5b + PD-L1 mAb)
Administration: Intraperitoneal injection (i.p.); once daily (QD); for 14 days
Result: Inhibited tumor growth as monotherapy (TGI = 27.5%) and showed higher tumor growth inhibition in combination with PD-L1 mAb (TGI = 36.2%), without significant body-weight loss.
Increased the proportion of activated CD3+CD8+ cytotoxic T cells in tumors (48.9% in combination group vs 31.8% in control).
Reduced Ki-67 expression and increased γ-H2AX signals in tumor tissues.
Showed no apparent histopathological abnormalities in major organs and no significant changes in serum biochemistry markers versus control.
分子量

374.43

Formula

C23H22N2O3

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Tubulin polymerization-IN-84
目录号:
HY-179372
需求量: